Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
0.700 | 0 | |||||||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
|
0.925 | 0.080 | 12 | 68839304 | missense variant | A/G | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||||||
|
0.925 | 0.080 | 12 | 68839304 | missense variant | A/G | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||||||
|
0.925 | 0.080 | 12 | 68839304 | missense variant | A/G | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.100 | 0.900 | 10 | 2006 | 2017 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.733 | 15 | 2007 | 2017 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.733 | 15 | 2007 | 2017 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2007 | 2019 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2007 | 2019 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 0.500 | 2 | 2007 | 2011 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 0.500 | 2 | 2007 | 2011 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Skin and Connective Tissue Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | < 0.001 | 1 | 2007 | 2007 |